Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $99,209 | 20 | 39.0% |
| Travel and Lodging | $73,627 | 80 | 28.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,512 | 31 | 24.2% |
| Education | $9,322 | 10 | 3.7% |
| Food and Beverage | $5,261 | 106 | 2.1% |
| Unspecified | $4,717 | 9 | 1.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $800.10 | 1 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105,465 | 65 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $54,080 | 110 | $0 (2023) |
| Genentech USA, Inc. | $42,351 | 25 | $0 (2019) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $14,834 | 6 | $0 (2017) |
| F. Hoffmann-La Roche AG | $10,995 | 16 | $0 (2020) |
| Olympus Corporation of the Americas | $9,322 | 10 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $6,826 | 8 | $0 (2019) |
| Genentech, Inc. | $4,623 | 3 | $0 (2018) |
| PneumRx, Inc | $2,525 | 1 | $0 (2017) |
| Boehringer Ingelheim Taiwan Ltd. | $2,100 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,613 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,613) |
| 2023 | $11,622 | 30 | Siemens Medical Solutions USA, Inc. ($9,858) |
| 2022 | $22,295 | 29 | Siemens Medical Solutions USA, Inc. ($15,210) |
| 2021 | $9,958 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,120) |
| 2020 | $19,090 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,229) |
| 2019 | $87,438 | 73 | Boehringer Ingelheim Pharmaceuticals, Inc. ($36,027) |
| 2018 | $43,892 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,269) |
| 2017 | $47,541 | 46 | Boehringer Ingelheim Pharma GmbH & Co.KG ($14,834) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $2,360.00 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $140.00 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $556.10 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $8,260.00 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $556.10 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $78.62 | General |
| 02/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $507.94 | General |
| Category: RESPIRATORY | ||||||
| 01/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $119.46 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $184.82 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Vida (Device) | Food and Beverage | In-kind items and services | $260.12 | General |
| Category: MR - MRI | ||||||
| 10/12/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Free.Max (Device) | Food and Beverage | In-kind items and services | $85.27 | General |
| Category: MR - MRI | ||||||
| 10/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $461.77 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Travel and Lodging | In-kind items and services | $143.20 | General |
| Category: MR - MRI | ||||||
| 09/14/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Free.Max (Device) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: MR - MRI | ||||||
| 09/14/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Free.Max (Device) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: MR - MRI | ||||||
| 09/13/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Free.Max (Device), NAEOTOM Alpha | Travel and Lodging | In-kind items and services | $219.25 | General |
| Category: MR - MRI | ||||||
| 09/13/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Travel and Lodging | In-kind items and services | $28.76 | General |
| Category: MR - MRI | ||||||
| 09/13/2023 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 09/13/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Travel and Lodging | In-kind items and services | $21.30 | General |
| Category: MR - MRI | ||||||
| 09/13/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Travel and Lodging | In-kind items and services | $17.04 | General |
| Category: MR - MRI | ||||||
| 09/13/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Free.Max (Device), MAGNETOM Sola | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: MR - MRI | ||||||
| 09/12/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Free.Max (Device), NAEOTOM Alpha | Travel and Lodging | In-kind items and services | $219.25 | General |
| Category: MR - MRI | ||||||
| 09/12/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Travel and Lodging | In-kind items and services | $21.29 | General |
| Category: MR - MRI | ||||||
| 09/12/2023 | Siemens Medical Solutions USA, Inc. | MAGNETOM Sola (Device) | Travel and Lodging | In-kind items and services | $17.42 | General |
| Category: MR - MRI | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF TOCILIZUMAB VERSUS PLACEBO IN PATIENTS WITH SYSTEMIC SCLEROSIS | F. Hoffmann-La Roche AG | $4,349 | 7 |
| A PHASE IIIII, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF TOCILIZUMAB VERSUS PLACEBO IN PATIENTS WITH SYSTEMIC SCLEROSIS, A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF TOCILIZUMAB VERSUS PLACEBO IN PATIENTS WITH SYSTEMIC SCLEROSIS | F. Hoffmann-La Roche AG | $368.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 834 | 6,885 | $926,532 | $121,316 |
| 2022 | 11 | 1,550 | 11,655 | $1.4M | $171,808 |
| 2021 | 11 | 1,398 | 11,102 | $1.4M | $177,927 |
| 2020 | 10 | 639 | 5,544 | $421,463 | $50,709 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 54 | 54 | $566,634 | $79,975 | 14.1% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 51 | 51 | $97,716 | $14,480 | 14.8% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 57 | 57 | $69,689 | $5,656 | 8.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 68 | 68 | $57,004 | $4,831 | 8.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 44 | 44 | $20,020 | $3,242 | 16.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 32 | 32 | $14,560 | $2,314 | 15.9% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 238 | 305 | $10,381 | $2,272 | 21.9% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 45 | 45 | $15,439 | $2,043 | 13.2% |
| 70491 | Ct scan of soft tissue of neck with contrast | Facility | 2023 | 31 | 31 | $10,523 | $1,706 | 16.2% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 30 | 30 | $7,075 | $1,306 | 18.5% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 11 | 11 | $4,763 | $785.51 | 16.5% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 60 | 6,039 | $30,195 | $740.83 | 2.5% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2023 | 14 | 14 | $4,537 | $724.68 | 16.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 24 | $10,776 | $621.65 | 5.8% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 75 | 80 | $7,220 | $616.91 | 8.5% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 64 | 65 | $683,795 | $96,997 | 14.2% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 61 | 62 | $118,792 | $17,692 | 14.9% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 149 | 153 | $208,074 | $15,912 | 7.6% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 157 | 161 | $208,987 | $14,029 | 6.7% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 528 | 727 | $24,742 | $5,435 | 22.0% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 87 | 90 | $31,054 | $4,059 | 13.1% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 51 | 51 | $23,205 | $3,570 | 15.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2022 | 45 | 46 | $20,930 | $3,199 | 15.3% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 74 | 75 | $18,665 | $3,172 | 17.0% |
| 70491 | Ct scan of soft tissue of neck with contrast | Facility | 2022 | 41 | 42 | $12,810 | $2,284 | 17.8% |
About Dr. Jonathan Goldin, MD
Dr. Jonathan Goldin, MD is a Diagnostic Radiology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477502144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Goldin, MD has received a total of $254,449 in payments from pharmaceutical and medical device companies, with $12,613 received in 2024. These payments were reported across 257 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($99,209).
As a Medicare-enrolled provider, Goldin has provided services to 4,421 Medicare beneficiaries, totaling 35,186 services with total Medicare billing of $521,760. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Los Angeles, CA
- Active Since 05/09/2006
- Last Updated 12/12/2019
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1477502144
Products in Payments
- OFEV (Drug) $72,738
- MAGNETOM Vida 3T (Device) $25,635
- MAGNETOM Vida (Device) $14,692
- Esbriet (Biological) $10,974
- Olympus Bronchoscopes (Device) $7,268
- Actemra (Biological) $4,717
- PNEUMRX COILS (Device) $2,525
- Olympus Capital Accessories (Device) $2,054
- MAGNETOM Free.Max (Device) $1,248
- SOMATOM Drive (Device) $1,157
- TIBSOVO (Drug) $800.10
- NAEOTOM Alpha (Device) $472.50
- MAGNETOM Sola (Device) $389.87
- STIOLTO RESPIMAT (Drug) $335.26
- Artis pheno (Device) $332.43
- MAGNETOM Prisma (Device) $329.66
- MAGNETOM Skyra (Device) $147.77
- Synapse PACS (MI) (Device) $135.76
- VISUAL-ICE (Device) $104.39
- SOMATOM Force (Device) $75.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Los Angeles
Edward Lee, Md, MD
Diagnostic Radiology — Payments: $1.3M
Dr. John Moriarty, M.d. Mrcpi Ffr(Rcsi), M.D. MRCPI FFR(RCSI)
Diagnostic Radiology — Payments: $866,087
Dr. Gary Ulaner, M.d. Ph.d, M.D. PH.D
Diagnostic Radiology — Payments: $560,607
Mary Yamashita, Md, MD
Diagnostic Radiology — Payments: $359,279
Dr. Arthur Baghdanian, Md, MD
Diagnostic Radiology — Payments: $270,314
Dr. Steven Raman, Md, MD
Diagnostic Radiology — Payments: $243,774